Navigation Links
Scientists Implicate Gene in Vitiligo and Other Autoimmune Diseases

BETHESDA, Md., April 10, 2007--In a study appearing in the March 22 New England Journal of Medicine, scientists supported by the National Institutes of Healths National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) have discovered a connection between a specific gene and the inflammatory skin condition vitiligo, as well as a possible host of autoimmune diseases.

Vitiligo is a chronic condition in which melanocytes (the cells that make pigment) in the skin are destroyed. As a result, white patches appear on the skin in different parts of the body. Similar patches also appear on both the mucous membranes (tissues that line the inside of the mouth and nose), and perhaps in the retina (inner layer of the eyeball). The hair that grows on areas affected by vitiligo sometimes turns white.

The researchers began a search for genes involved in vitiligo almost a decade ago with the help of the Vitiligo Society in the United Kingdom. In the beginning we were looking for multiple family members with vitiligo, says Richard Spritz, M.D., director of the Human Medical Genetics Program at the University of Colorado at Denver and Health Sciences Center and lead investigator for the study. The researchers sent a questionnaire to members of the society, asking them about their own vitiligo and whether other family members were affected. As part of the questionnaire, they also asked about other autoimmune diseases. What they learned was that vitiligo was very highly associated with a number of other autoimmune diseases, mostly thyroid disease, but also pernicious anemia, rheumatoid arthritis, psoriasis, lupus, Addisons disease, and adult-onset autoimmune diabetes.

That finding prompted the researchers to study families with multiple affected members and to look for similarities in genes among those who were affected. By searching the genome, they discovered a gene, NALP1, that was key to
'"/>




Page: 1 2 3

Related medicine technology :

1. Rosetta Genomics and Weizmann Institute Scientists Identify Role of microRNA in Cancer Suppression
2. Schepens Scientists Identify Key to Integrating Transplanted Nerve Cells Into Injured Tissue
3. Karmanos Physician-Scientists Examine Racial Disparities in Patients with Gynecologic Cancer
4. The Sturdier Sex?: Study by Pittsburgh Scientists Finds Female Stem Cells Work Better
5. Alnylam and Stanford University Scientists Discover New Role for microRNAs (miRNAs) in T Cell Biology and Immunity
6. Scottish Scientists Test ‘Secret Weapon’ Against Tumours
7. Exforge Helps Vast Majority of Patients Effectively Control Their Blood Pressure After Failing on Other Medicines, According to New Clinical Data
8. Othera Pharmaceuticals Announces Upcoming Presentation Based Upon Expanded Understanding of Lead Compound Mechanism of Action
9. New One-Year Pharmacoeconomic Study Shows Avonex is Cost-Effective Relative to Other Interferon Therapies for Multiple Sclerosis
10. Targanta Reports Improved Ability of Oritavancin to Stop Bacteria Growth In Vitro Compared With Other Glycopeptide Antibiotics
11. Xanthus Presents Novel Approach for Autoimmune Disease Reversal with Symadex
Post Your Comments:
(Date:5/15/2008)...a newly cleared device to identify the, lipid cor...sociated with complications of c...wswire/ -- InfraReDx, Inc. today,announced that ph... have,successfully used its LipiScan(TM) Coronary ...atheterization. This is the first patient in the,w...
(Date:5/15/2008)...RNewswire/ -- Tigris Pharmaceuticals,Inc. announc...nd,Development Agreement (CRADA) with the National... and preclinical development of AFP-464, an,aminof...s converted to,metabolites which bind covalently t... This is part of a four-year CRADA encompassing m...
(Date:5/15/2008)... CEA Trial data reports in third quarter ... /- VIA Pharmaceuticals,In...ed on the development of,compounds for the treatme...,it has completed patient enrollment in its acute ...e of three Phase 2 trials investigating VIA-2291,...
(Date:5/14/2008)...Newswire-FirstCall/ -- Progen,Pharmaceuticals Limi...he,Company has resumed patient enrolment in the ph...ed polyamine analogue, PG-11047 (formerly CGC-1104... commenced development of PG-11047 - the lead clin... following its acquisition of,Cellgate, Inc earlie...
Breaking Medicine Technology:First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 2First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 3First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 4Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 2Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 3VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 2VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 3VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 4VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 5Progen Resumes Phase 1 Development of Anti-Cancer Agent, PG-11047 2Study by Pittsburgh researchers identifies possible vaccine target for chlamydia 358 1Study by Pittsburgh researchers identifies possible vaccine target for chlamydia 358 2A step toward tissue engineered heart structures for children 355 1A step toward tissue engineered heart structures for children 355 2Microbiotic technology developed for microinjection of zebrafish embryos 1069 1Mathematics might save you a trip to the ER 1066 1Mathematics might save you a trip to the ER 1066 2
...-May 21, 2007 - Medical,professionals seeking to t...cquired gram-negative pneumonia may have a new wea...ct candidate being,developed by Nektar Therapeutic...rial evaluating the use of,NKTR-061 (Inhaled Amika...h hospital-acquired gram-negative pneumonia were,p...
...ed by FDA for long-term,maintenance treatment of C...bulized formoterol fumarate provides improved lung...anced patient quality of,life, and positive safety... presented at the,International Conference of the ...erforomist™ (formoterol fumarate),Inhalation...
Other Medicine Technology:Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 2Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 3Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 4Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 5Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 6Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 7Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 8Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 9Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 10Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 11Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 2Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 3Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 4Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 5Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 6Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 7
(Date:5/16/2008)...this country needs is more unemployed politicians ...ire-FirstCall/ -- Although nearly all,voters place...ssues" list,a looming federal budgetary crunch me...of the current presidential candidates is likely t... Majority Leader Bill Frist., Jousting with Princ...
(Date:5/16/2008)...RISBURG, Pa., May 16 /PRNewswire-USNewswire/ -- Em...opportunity to highlight the dedication,of Pennsyl...ns to become,trained EMS volunteers, according to ...is year,s theme, "EMS: Your Life is Our Mission," ... when it occurs, EMS is there to provide,immediate...
(Date:5/16/2008)...HINGTON, May 16 /PRNewswire-USNewswire/ -- As trop...f the Irrawaddy delta, survivors of,Cyclone Nargis...ems. Many,survivors still need assistance, as expo...ting an increasingly dire situation., "The people...p to,recover from this disaster and get back on th...
(Date:5/16/2008)...ppeals for Funds Focus on Millions of Children Sti...e U.S. Fund for UNICEF and The,Advertising Council...romote,a series of national public service announc...ing Ben Stiller, Nicole Ritchie, Joel Madden, Davi... to help survivors of the,Myanmar cyclone. The Ad ...
Breaking Medicine News(10 mins):Health News:Former Senate Majority Leader, Princeton Economist Joust on Future of Health Care 2Health News:Former Senate Majority Leader, Princeton Economist Joust on Future of Health Care 3Health News:PA Secretary of Health Announces 'Emergency Medical Services Week,' May 18 - 24 2Health News:Myanmar Cyclone Survivors Face New Challenges 2Health News:Video: The Ad Council Partners With UNICEF to Promote and Distribute Myanmar Cyclone PSAs Filmed by A-List Celebrities 2Health News:Video: The Ad Council Partners With UNICEF to Promote and Distribute Myanmar Cyclone PSAs Filmed by A-List Celebrities 3
... records have been hailed as a key element in maki... but a new study led by a researcher at the Stanf...ronic records were not associated with improved qu... and 2004. Of 17 quality indicators assessed by t...
... Chinese soldier is immaculate -- backed by sturdy...e , qualifications and even his height. Next to i...Beijing's Zhongshan Park, are two photographs, one...d bachelor proudly donning his military uniform. ...
... scientists claims they can soon release the worl...zheimers . If so, the NHS Trust of UK will stand t...disease, one of the most common neurological dise...S up to 17 billion pounds per year. According to t...
... services in London are long overdue but it is unc...Strategic Health Authority, would improve patient ...rth, chairman of the BMAs London Regional Council,...how some services are provided in London but docto...
Other Medicine News:Health News:Electronic Health Records Shows No Improvement in Quality of Outpatient Care 2Health News:Electronic Health Records Shows No Improvement in Quality of Outpatient Care 3Health News:Parental Match-making Blossoms in a Beijing Park 2Health News:Parental Match-making Blossoms in a Beijing Park 3Health News:Simple Blood Test May Predict Alzheimers Disease 2Health News:Polyclinics Could Threaten NHS Services, Warns BMA 2
Aaron manufactures two groups of flexible lighting products. The first is available both sterile and non-sterile in three different sizes 5", 10", and 15" (refers to the flexible shaft portion of the
These units, though small, still offer sufficient output to ensure current is fully adjustable from 0 to 70 mA. Instruction manual, ball electrodes, battery and leads with alligator clips are include
These units, though small, still offer sufficient output to ensure current is fully adjustable from 0 to 70 mA. Instruction manual, ball electrodes, battery and leads with alligator clips are include
...des of Operation: , Standby: A standby switch main...timulus pulses. , Double Burst : 2 60-ms bursts of...itch: 1 s (1 pulse/s); 2 Hz (2 pulses/s) , Tetanu...Train-Of-Four: 4 pulses/2 s; repeats every 10 s , ...
Medicine Products: